SG11202000817SA - Carbamoyl phenylalaninol analogs and uses thereof - Google Patents
Carbamoyl phenylalaninol analogs and uses thereofInfo
- Publication number
- SG11202000817SA SG11202000817SA SG11202000817SA SG11202000817SA SG11202000817SA SG 11202000817S A SG11202000817S A SG 11202000817SA SG 11202000817S A SG11202000817S A SG 11202000817SA SG 11202000817S A SG11202000817S A SG 11202000817SA SG 11202000817S A SG11202000817S A SG 11202000817SA
- Authority
- SG
- Singapore
- Prior art keywords
- analogs
- phenylalaninol
- carbamoyl
- carbamoyl phenylalaninol
- phenylalaninol analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/02—Monothiocarbamic acids; Derivatives thereof
- C07C333/04—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762539088P | 2017-07-31 | 2017-07-31 | |
PCT/US2018/044465 WO2019027941A1 (fr) | 2017-07-31 | 2018-07-31 | Analogues de carbamoyl phénylalaninol et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202000817SA true SG11202000817SA (en) | 2020-02-27 |
Family
ID=65233074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202000817SA SG11202000817SA (en) | 2017-07-31 | 2018-07-31 | Carbamoyl phenylalaninol analogs and uses thereof |
Country Status (11)
Country | Link |
---|---|
US (2) | US11413264B2 (fr) |
EP (1) | EP3661911A4 (fr) |
JP (2) | JP7366002B2 (fr) |
KR (1) | KR102643275B1 (fr) |
CN (1) | CN111094238B (fr) |
AU (1) | AU2018312328B2 (fr) |
CA (1) | CA3071779A1 (fr) |
MX (2) | MX2020001146A (fr) |
RU (1) | RU2020108634A (fr) |
SG (1) | SG11202000817SA (fr) |
WO (1) | WO2019027941A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
WO2023235844A2 (fr) * | 2022-06-03 | 2023-12-07 | Axsome Therapeutics | Composés de carbamoyl phénylalaninol utiles en tant qu'agonistes de taar1 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2604434B1 (fr) * | 1986-09-29 | 1989-05-19 | Inst Nat Sante Rech Med | Derives d'amino-2 ethanethiol, leur preparation et leur application en therapeutique |
KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
EP0873308B1 (fr) * | 1996-10-10 | 2002-01-02 | SK Corporation | Composes de o-carbamoyl-phenylalaninol et sels de ces composes utiles sur le plan pharmaceutique |
AU4674797A (en) * | 1996-10-22 | 1998-05-15 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
US5935997A (en) * | 1998-01-13 | 1999-08-10 | Yukong Limited | O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically useful salts and process for preparing the same |
CA2355293C (fr) | 1998-12-23 | 2005-08-16 | Orphan Medical, Inc. | Solutions de sel d'hydroxybutyrate stables et saines au plan microbiologique, pour le traitement de la narcolepsie |
PL349354A1 (en) * | 1999-01-28 | 2002-07-15 | Chugai Pharmaceutical Co Ltd | Substituted phenethylamine derivatives |
ES2209384T3 (es) * | 1999-02-05 | 2004-06-16 | Sk Corporation | Compuestos de o-tiocarbamoilaminoalcanol, sus sales farmaceuticamente aceptables y proceso para preparar los mismos. |
WO2000064865A1 (fr) * | 1999-04-23 | 2000-11-02 | Solvay Pharmaceuticals B.V. | Monomeres et peptidomimetiques d'oligo-uree, et leur procede de preparation |
US6680322B2 (en) | 1999-12-02 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
EP1264814A1 (fr) * | 2001-06-08 | 2002-12-11 | Avantium International B.V. | Agents de résolution à base d'amines |
US6680299B2 (en) | 2001-07-27 | 2004-01-20 | Enanta Pharmaceuticals, Inc. | 4'-substituted leucomycins |
KR100576372B1 (ko) * | 2001-08-03 | 2006-05-03 | 에스케이 주식회사 | O-티오카바모일-아미노알카놀 화합물, 이의 약학적 허용염 및 제조방법 |
ITFI20030113A1 (it) * | 2003-04-24 | 2004-10-25 | Menarini Ricerche Spa | Composti lineari nk-2 antagonisti con caratteristiche basiche e formulazioni che li contengono. |
BRPI0518233A2 (pt) | 2004-10-28 | 2008-11-11 | Sk Corp | terapia adjunta para depressço |
JP5024635B2 (ja) * | 2005-06-08 | 2012-09-12 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 睡眠覚醒障害の治療 |
KR101335942B1 (ko) | 2005-06-22 | 2013-12-04 | 에스케이바이오팜 주식회사 | 성기능 장애의 치료 |
CN101823987B (zh) * | 2009-03-06 | 2014-06-04 | 中国科学院上海药物研究所 | 一类新的dpp-ⅳ抑制剂及其制备方法和用途 |
RU2567801C2 (ru) | 2009-06-22 | 2015-11-10 | Ск Биофармасъютиклс Ко., Лтд. | Способы лечения и профилактики усталости |
US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
JP5901528B2 (ja) | 2009-11-06 | 2016-04-13 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 線維筋痛症候群の治療方法 |
CA2779457C (fr) | 2009-11-06 | 2017-10-17 | Sk Biopharmaceuticals Co., Ltd. | Procedes pour traiter un trouble de deficit de l'attention avec hyperactivite |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
CN102249833B (zh) * | 2011-05-27 | 2013-12-11 | 中国科学院化学研究所 | 一种制备手性γ-氨基酸及其衍生物的方法 |
US9050302B2 (en) | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
MX2015012644A (es) | 2013-03-13 | 2016-06-21 | Aerial Biopharma Llc | Tratamiento de cataplejia. |
JP2016530240A (ja) | 2013-07-12 | 2016-09-29 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドJazz Pharmaceuticals International Iii Limited | 禁煙の促進 |
KR102309836B1 (ko) | 2013-07-18 | 2021-10-12 | 에스케이바이오팜 주식회사 | 비만의 치료 |
WO2017007695A1 (fr) * | 2015-07-09 | 2017-01-12 | The Regents Of The University Of California | Modulateurs du récepteur opioïde de type mu |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
EP4316592A3 (fr) | 2016-10-06 | 2024-05-01 | Axsome Malta Ltd. | Composés de carbamoyl phénylalaninol et leurs utilisations |
-
2018
- 2018-07-31 EP EP18840981.7A patent/EP3661911A4/fr active Pending
- 2018-07-31 JP JP2020505344A patent/JP7366002B2/ja active Active
- 2018-07-31 WO PCT/US2018/044465 patent/WO2019027941A1/fr active Application Filing
- 2018-07-31 US US16/634,935 patent/US11413264B2/en active Active
- 2018-07-31 KR KR1020207005652A patent/KR102643275B1/ko active IP Right Grant
- 2018-07-31 CA CA3071779A patent/CA3071779A1/fr active Pending
- 2018-07-31 AU AU2018312328A patent/AU2018312328B2/en active Active
- 2018-07-31 SG SG11202000817SA patent/SG11202000817SA/en unknown
- 2018-07-31 RU RU2020108634A patent/RU2020108634A/ru unknown
- 2018-07-31 CN CN201880059970.5A patent/CN111094238B/zh active Active
- 2018-07-31 MX MX2020001146A patent/MX2020001146A/es unknown
-
2020
- 2020-01-29 MX MX2023005484A patent/MX2023005484A/es unknown
-
2022
- 2022-06-16 US US17/841,976 patent/US20220401401A1/en active Pending
-
2023
- 2023-04-26 JP JP2023072520A patent/JP2023100758A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
Also Published As
Publication number | Publication date |
---|---|
US11413264B2 (en) | 2022-08-16 |
WO2019027941A1 (fr) | 2019-02-07 |
CA3071779A1 (fr) | 2019-02-07 |
RU2020108634A3 (fr) | 2021-11-30 |
CN111094238B (zh) | 2023-06-09 |
MX2023005484A (es) | 2023-05-18 |
EP3661911A4 (fr) | 2021-04-14 |
AU2018312328A1 (en) | 2020-03-19 |
MX2020001146A (es) | 2020-08-20 |
EP3661911A1 (fr) | 2020-06-10 |
US20210093603A1 (en) | 2021-04-01 |
CN111094238A (zh) | 2020-05-01 |
RU2020108634A (ru) | 2021-09-02 |
AU2018312328B2 (en) | 2022-12-15 |
KR20200045489A (ko) | 2020-05-04 |
JP2023100758A (ja) | 2023-07-19 |
US20220401401A1 (en) | 2022-12-22 |
KR102643275B1 (ko) | 2024-03-04 |
JP7366002B2 (ja) | 2023-10-20 |
JP2020530837A (ja) | 2020-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202000817SA (en) | Carbamoyl phenylalaninol analogs and uses thereof | |
IL273236A (en) | Pyrazolopyrimidine compounds and their uses | |
AU201810296S (en) | Band | |
SG11202004341YA (en) | Cosmetic mask | |
IL290897A (en) | Minimal saponin analogues, their synthesis and use | |
GB201708652D0 (en) | Novel compounds and uses | |
HK1248069A1 (zh) | 去乙酰氧基微管溶素h及其類似物 | |
GB201714745D0 (en) | New compounds and uses | |
GB201714740D0 (en) | New compounds and uses | |
SG11202004877UA (en) | Sulfonamide compounds and use thereof | |
ZA201907833B (en) | Heteroarylphenylaminoquinolines and analogues | |
EP3609504A4 (fr) | Nouveaux analogues d'oxaborole et utilisations de ces derniers | |
GB201714734D0 (en) | New compounds and uses | |
GB201714736D0 (en) | New compounds and uses | |
GB201712110D0 (en) | New compounds and uses | |
HK1217689A1 (zh) | 及其生物活性類似物的合成 | |
EP3246312A4 (fr) | Composé carbamate et son utilisation | |
EP3246314A4 (fr) | Composé carbamate et utilisation associée | |
EP3246319A4 (fr) | Composé de carbamate et son utilisation | |
HK1256416A1 (zh) | Glucosepane的全合成和由此獲得的化合物 | |
GB201705352D0 (en) | Cosmetic Mask | |
GB201603591D0 (en) | Improved promotors and compositions | |
EP3246316A4 (fr) | Composé carbamate et utilisation associée | |
EP3246318A4 (fr) | Composé de type carbamate et son utilisation | |
GB201613032D0 (en) | A-lice band |